Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2010
05/12/2010CN1915992B Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1802372B 7-[(1,3-thiazol-2-yl)thio]-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
05/12/2010CN1798559B Quinoline-2-one-derivatives for the treatment of airways diseases
05/12/2010CN1642929B Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
05/12/2010CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101096369B Oxazolidinone compound containing thiadiazoles groups and preparation method thereof
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714137 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide; Hepatitis C virus
05/11/2010US7714130 To a suspension of 2-(4-t-butylphenyl)-4-piperazin-1-yl-1H-benzimidazole and potassium carbonate in acetone was added 6-bromomethylquinoxaline to produce 2-(4-tert-butylphenyl)4-{[4-(6-quinoxalyl)methyl]piperazin-1-yl}benzimidazole Dihydrochloride Dihydrate
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713987 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
05/11/2010US7713983 Voltage gated sodium and calcium channel inhibitors
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713962 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and/or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination
05/11/2010CA2536544C 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010051236A1 Isonicotinamide orexin receptor antagonists
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010WO2010049331A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/06/2010WO2009007098A8 Isothiazole and pyrazole derivatives as fungicides
05/06/2010US20100113789 Medicinal composition for prevention or treatment of parasitic protozoan infection
05/06/2010US20100113783 Process for the preparation of crystals of prulifloxacin
05/06/2010US20100113532 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
05/06/2010US20100113531 Thiazolidine derivatives as orexin receptor antagonists
05/06/2010US20100113467 Organic Compounds
05/06/2010US20100113439 Antifungal agents
05/06/2010US20100113436 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113430 Thioxanthene derivates useful to treat infectious diseases
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113305 Oxazole and thiazole combinatorial libraries
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010CA2741644A1 Isonicotinamide orexin receptor antagonists
05/06/2010CA2741325A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2181994A1 Antimicrobial compounds
05/05/2010EP2181993A1 Antimicrobial oxazolidinone derivatives
05/05/2010EP2181987A1 Heterocyclic compound and use thereof
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181111A1 Thiadiazinone derivatives
05/05/2010EP2181110A2 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181101A2 Tubulysin d analogues
05/05/2010EP2181092A1 1,3-dihydroisoindole derivatives
05/05/2010EP1997813B1 Substituted isoxazoline compound and pest control agent
05/05/2010EP1558607B1 Compositions useful as inhibitors of rock and other protein kinases
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1167366B1 Amine derivatives
05/05/2010CN1930157B Silylierte carboxamide
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/05/2010CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain.
05/05/2010CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
05/05/2010CN101702907A Piperazine compounds with a herbicidal action
05/05/2010CN101701018A 2-(4-aminoquinazoline) benzo [d] thiazole derivative and application thereof
05/05/2010CN101023079B Substituted hydantoins for the treatment of cancer
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709661 Indole is treated with an aldehyde in the presence of a Lewis acid and a silicon hydride reducing agent, alkylating the C-3 position of indoles that contain acid-sensitive substituents at the N-1 position
05/04/2010US7709510 Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
05/04/2010US7709509 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes
05/04/2010US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate;
05/04/2010US7709500 Chemical compounds
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709479 Quinazoline derivatives and their use as pharmaceuticals
05/04/2010US7709475 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity
05/04/2010US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2439001C Water-soluble triazole antifungal agents
05/04/2010CA2399196C Pyrimidine compounds
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/04/2010CA2282439C Formulations for hydrophobic pharmaceutical agents
04/2010
04/29/2010WO2010046931A2 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof
04/29/2010WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105914 Caspase inhibitors and uses thereof
04/29/2010US20100105905 EP2 Agonists
04/29/2010US20100105900 Inhibitors of carnitine palmitoyltransferase and treating cancer
04/29/2010US20100105897 Novel quinuclidine derivative useful in the preparation of mequitazine
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105814 Ultraviolet absorbent and polymer material containing the same
04/29/2010US20100105767 Compounds, compositions and methods
04/29/2010US20100105739 Modulators of atp-binding cassette transporters
04/29/2010US20100105711 Organic Compounds